Phase
Condition
Sarcopenia
Treatment
Whey protein
Clinical Study ID
Ages 18-80 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
- In order to be eligible to participate in this study, a patient with CKD must meet all of the following criteria:
(e)glomerular filtration rate (GFR) <45 ml/min/1.73m2
Age: 18 - 80 y
Able to provide written informed consent
- In order to be eligible to participate in this study, a healthy subject must meet all of the following criteria:
(e)GFR >60 ml/min/1.73m2 without albuminuria
Age: 18 - 80 y
Able to provide written informed consent
- A potential subject with CKD who meets any of the following criteria will be excluded from participation in this study:
Insulin-dependent diabetes mellitus or two or more oral glucose lowering medications
Active inflammatory disease / malignancies
Uncontrolled hypertension (>160/100mm Hg), unstable angina pectoris, or arrhythmia
Pulmonary disease restricting exercise performance (e.g. COPD)
A history of neuromuscular problems
Cognitive Impairment
Diagnosed GI tract diseases / dysphagia
Allergies to milk proteins / Lactose intolerance
Pregnancy
Hospitalization <1 months prior to study period
Participation in any structured exercise program
Any medications known to affect protein metabolism (i.e. corticosteroids or prescription strength acne medications).
Use of DOAC, vitamin-K-antagonist, or multiple anticoagulants.
Dialysis treatment or previous kidney transplantation
- A potential healthy subject who meets any of the following criteria will be excluded from participation in this study:
Insulin-dependent diabetes mellitus or two or more oral glucose lowering medications
Active inflammatory disease / malignancies
Uncontrolled hypertension (>160/100mm Hg), unstable angina pectoris, or arrhythmia
Pulmonary disease restricting exercise performance (e.g. COPD)
A history of neuromuscular problems
Cognitive Impairment
Diagnosed GI tract diseases / dysphagia
Allergies to milk proteins / Lactose intolerance
Pregnancy
Hospitalization <1 months prior to study period
Participation in any structured exercise program
Any medications known to affect protein metabolism (i.e. corticosteroids or prescription strength acne medications).
Use of DOAC, vitamin-K-antagonist, or multiple anticoagulants.
Study Design
Connect with a study center
Maastricht University Medical Center+
Maastricht, Limburg 6229ER
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.